Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus RecommendationsFunda Meric‐Bernstam, Jeffrey A. Moscow, Larry Rubinstein et al.|Molecular Cancer Therapeutics|2024Cited by 21
Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 InhibitorSuet‐Ying Kwan, Laura Beretta, Alyssa N. Slayden et al.|Cancer Prevention Research|2022Cited by 8
Supplementary Data from Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 InhibitorSuet‐Ying Kwan, Laura Beretta, Alyssa N. Slayden et al.|Unknown|2023Cited by 0
Supplementary Data from Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 InhibitorSuet‐Ying Kwan, Laura Beretta, Alyssa N. Slayden et al.|Unknown|2025Cited by 0